Morgan Stanley analyst David Phung maintains Eli Lilly (NYSE:LLY) with a Overweight and lowers the price target from $448 to $445.
Morgan Stanley analyst David Phung maintains Eli Lilly (NYSE:LLY) with a Overweight and lowers the price target from $448 to $445.